Detalles de la búsqueda
1.
Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors as First-Line Therapy.
Cancer Manag Res
; 14: 3191-3202, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36415537
Resultados
1 -
1
de 1
1
Próxima >
>>